The influence of adipose tissue volume can significantly affect the metabolic activity of reference organs in 18F-FDG PET/CT studies of a normal healthy population

Hell J Nucl Med. 2017 Sep-Dec;20(3):211-216. doi: 10.1967/s002449910605. Epub 2017 Nov 27.

Abstract

Objective: This study investigated whether fluorine-18-fluorodeoxyglucose (18F-FDG) uptake of reference organs can be affected by subjects' factors in positron emission tomography/computed tomography (PET/CT) in a healthy population.

Subjects and methods: A total of 208 normal healthy subjects without diabetes or dyslipidemia were included. Adipose tissue volume was measured by CT images from a dedicated PET/CT scan. Uptake of 18F-FDG of reference organs was measured from liver, blood pool, and muscle, and was normalized by lean body anthropometric data and adipose tissue volume.

Results: Of 208 participants, 118 were metabolically healthy lean (MHL); with body mass index (BMI) <25kg/m2 and 90 were metabolically healthy obese (MHO) with; BMI≥25kg/m2 . These subjects had significantly higher values of liver, blood pool, and muscle than did the MHL subjects (P<0.001 for both). Among subjects' factors, adipose tissue volume revealed strongest correlation with standardized uptake value multiplied by lean body weight divided by body weight (SUL) of liver (r=0.754, P<0.001), of blood pool (r=0.756, P<0.001) and of muscle (r=0.635, P<0.001). On regression analysis, adipose tissue volume was determined to be a common independent predictor for SUL of liver, blood pool and muscle (P<0.001) and furthermore was serum C-reactive protein level for SUL of the liver and also age and serum insulin level for SUL of blood pool.

Conclusion: Adipose tissue volume can significantly affect SUL of liver, blood pool, and muscle in a healthy population. Liver and blood pool may have limited roles as reference organs for normalization of 18F-FDG uptake of the lesion.

MeSH terms

  • Adipose Tissue / anatomy & histology
  • Adipose Tissue / physiology*
  • Adult
  • Artifacts*
  • Female
  • Fluorodeoxyglucose F18 / pharmacokinetics*
  • Humans
  • Male
  • Metabolic Clearance Rate / physiology
  • Organ Size
  • Organ Specificity / physiology
  • Positron Emission Tomography Computed Tomography / methods*
  • Positron Emission Tomography Computed Tomography / standards*
  • Radiopharmaceuticals / pharmacokinetics
  • Reference Values
  • Reproducibility of Results
  • Republic of Korea
  • Sensitivity and Specificity
  • Tissue Distribution
  • Viscera / metabolism*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18